DALLAS PROVENCE: Open Payments
NPI 1619556230 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,788 in 86 payments from 17 companies in 2025. Trend: 2023 $2,223 · 2024 $1,786 · 2025 $1,788
Food & beverage: $1,708Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $440 |
| GENZYME CORPORATION | 12 | $285 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $177 |
| UCB, Inc. | 6 | $130 |
| LEO Pharma Inc. | 5 | $118 |
| Organon LLC | 6 | $92 |
| Janssen Biotech, Inc. | 5 | $86 |
| Lilly USA, LLC | 4 | $80 |
| Amgen Inc. | 3 | $68 |
| Incyte Corporation | 2 | $59 |
Products named: SKYRIZI, DUPIXENT, Bimzelx, ADBRY, TREMFYA, ILUMYA, OTEZLA, EBGLYSS.
Industry payments across TN — which companies pay providers there.
